Preclinical Imaging Market Size, Trends and Analysis 2034
Global Preclinical Imaging Market Size- By Product, By Application, By End-use- Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Sep-2025 | Report ID: MEDE2556 | Pages: 1 - 259 | Formats*: |
| Category : Medical Devices | |||
Global Preclinical Imaging Market Introduction and Overview
According to SPER Market Research, the Global Preclinical Imaging Market is estimated to reach USD 7187.47 million by 2034 with a CAGR of 4.65%.
The report includes an in-depth analysis of the Global Preclinical Imaging Market, including market size and trends, product mix, Applications, and supplier analysis. The Global Preclinical Imaging market was valued at USD XX billion in 2024 and is projected to increase at a compound annual growth rate (CAGR) of XX% between 2025 and 2034. The growth of the global market is mainly driven by increased investments and funding in research and development, which promote innovation, technological advancements, and the development of new products and solutions across various industries worldwide.
By Product Insights
The optical imaging segment holds the largest revenue share due to its extensive use in small animal imaging and drug discovery. Advances in molecular imaging and demand for non-invasive techniques drive its adoption. Increased investments in preclinical research and rising healthcare expenditure further boost market growth.
The multimodal segment is expected to grow the fastest as combining multiple imaging modalities improves sensitivity and specificity. This integration overcomes individual limitations, providing more accurate data. As technology evolves, multimodal imaging will become increasingly vital in advancing disease understanding and therapy development in preclinical research.
By Application Insights
The research & development segment held the largest revenue share in 2024, driven by extensive clinical trials for diseases like Alzheimer’s, cancer, and neurological disorders led by organizations such as the NIH. Collaborations between CROs and academic health systems provide access to large patient populations and strong infrastructure, enhancing clinical research capabilities. For example, Canada’s vast network of research centers and medical schools supports advanced clinical studies, fueling innovation in imaging technologies and preclinical research, ultimately advancing biomedical science and improving patient outcomes. The drug discovery segment is expected to grow the fastest, as preclinical imaging plays a key role in assessing drug safety, efficacy, and pharmacokinetics before clinical trials. This segment focuses on identifying new drug targets, evaluating effects in animal models, and optimizing development processes. Preclinical imaging also supports personalized medicine by enabling tailored treatments based on individual disease characteristics. For instance, a 2023 study by Eli Lilly showed that solanezumab did not slow cognitive decline in preclinical Alzheimer’s patients, highlighting the challenges in drug development despite advanced imaging techniques.
Regional Insights
North America held the largest share of the preclinical imaging market in 2024, driven by its well-established research infrastructure, skilled workforce, numerous preclinical projects, and high adoption of advanced imaging technologies.
Market Competitive Landscape
Market players focus on strategic initiatives to maintain a strong market presence, with continuous innovation being a key area. They frequently launch and upgrade preclinical imaging systems that improve resolution, sensitivity, and data analysis, meeting the evolving needs of researchers and pharmaceutical developers to advance drug discovery and disease research. Some key players are- Agilent Technologies, Bruker Corporation, FUJIFILM SonoSite, General Electric (GE), Mediso Ltd., MILabs B.V., Molecubes, MR Solutions, PerkinElmer, Inc., Siemens A.G., and TriFoil Imaging..
Recent Developments:
In April 2024, Spectral Instruments Imaging launched Aura 4.5, the latest version of its in vivo imaging software.
In April 2023, Southern Scientific became the new UK distributor for Spectral Instruments Imaging, a leading manufacturer of preclinical in vivo imaging systems.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product, By Application, By End-use |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Agilent Technologies, Bruker Corporation, FUJIFILM SonoSite, General Electric (GE), Mediso Ltd., MILabs B.V., Molecubes, MR Solutions, PerkinElmer, Inc., Siemens A.G., and TriFoil Imaging. |
Key Topics Covered in the Report
- Global Preclinical Imaging Market Size (FY’2021-FY’2034)
- Overview of Global Preclinical Imaging Market
- Segmentation of Global Preclinical Imaging Market By Product (CT Imaging, MRI Imaging, PET/SPECT Imaging, Multi-modal Imaging, Optical Imaging, Ultrasound Imaging, Photoacoustic Imaging, Reagents, Services)
- Segmentation of Global Preclinical Imaging Market By Application (Research and Development, Drug Discovery)
- Segmentation of Global Preclinical Imaging Market By End-use (Pharma and Biotech Companies, Research Institutes, Others)
- Statistical Snap of Global Preclinical Imaging Market
- Expansion Analysis of Global Preclinical Imaging Market
- Problems and Obstacles in Global Preclinical Imaging Market
- Competitive Landscape in the Global Preclinical Imaging Market
- Details on Current Investment in Global Preclinical Imaging Market
- Competitive Analysis of Global Preclinical Imaging Market
- Prominent Players in the Global Preclinical Imaging Market
- SWOT Analysis of Global Preclinical Imaging Market
- Global Preclinical Imaging Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape
5.3.PORTERs Five Forces
5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Preclinical Imaging Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Preclinical Imaging Market
7.Global Preclinical Imaging Market, By Product (USD Million) 2021-2034
7.1.CT Imaging7.2.MRI Imaging7.3.PET/SPECT Imaging7.4.Multi-modal Imaging7.5.Optical Imaging7.6.Ultrasound Imaging7.7.Photoacoustic Imaging7.8.Reagents7.9.Services
8.Global Preclinical Imaging Market, By Application (USD Million) 2021-2034
8.1.Research and Development8.2.Drug Discovery
9.Global Preclinical Imaging Market, By End use (USD Million) 2021-2034
9.1.Pharma and Biotech Companies9.2.Research Institutes9.3.Others
10.Global Preclinical Imaging Market, (USD Million) 2021-2034
10.1.Global Preclinical Imaging Market Size and Market Share
11.Global Preclinical Imaging Market, By Region, (USD Million) 2021-2034
11.1.Asia-Pacific
11.1.1.Australia11.1.2.China11.1.3.India11.1.4.Japan11.1.5.South Korea11.1.6.Rest of Asia-Pacific
11.2.Europe
11.2.1.France11.2.2.Germany11.2.3.Italy11.2.4.Spain11.2.5.United Kingdom11.2.6.Rest of Europe
11.3.Middle East and Africa
11.3.1.Kingdom of Saudi Arabia11.3.2.United Arab Emirates11.3.3.Qatar11.3.4.South Africa11.3.5.Egypt11.3.6.Morocco11.3.7.Nigeria11.3.8.Rest of Middle-East and Africa
11.4.North America
11.4.1.Canada11.4.2.Mexico11.4.3.United States
11.5.Latin America
11.5.1.Argentina11.5.2.Brazil11.5.3.Rest of Latin America
12.Company Profile
12.1. Agilent Technologies
12.1.1.Company details12.1.2.Financial outlook12.1.3.Product summary12.1.4.Recent developments
12.2. Bruker Corporation
12.2.1.Company details12.2.2.Financial outlook12.2.3.Product summary12.2.4.Recent developments
12.3. FUJIFILM SonoSite
12.3.1.Company details12.3.2.Financial outlook12.3.3.Product summary12.3.4.Recent developments
12.4. General Electric (GE)
12.4.1.Company details12.4.2.Financial outlook12.4.3.Product summary12.4.4.Recent developments
12.5. Mediso Ltd.
12.5.1.Company details12.5.2.Financial outlook12.5.3.Product summary12.5.4.Recent developments
12.6. MILabs B.V.
12.6.1.Company details12.6.2.Financial outlook12.6.3.Product summary12.6.4.Recent developments
12.7. Molecubes
12.7.1.Company details12.7.2.Financial outlook12.7.3.Product summary12.7.4.Recent developments
12.8. MR Solutions
12.8.1.Company details12.8.2.Financial outlook12.8.3.Product summary12.8.4.Recent developments
12.9. PerkinElmer, Inc.
12.9.1.Company details12.9.2.Financial outlook12.9.3.Product summary12.9.4.Recent developments
12.10. Siemens A.G.
12.10.1.Company details12.10.2.Financial outlook12.10.3.Product summary12.10.4.Recent developments
12.11.Others
13.Conclusion
14.List of Abbreviations
15.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Preclinical Imaging Market is projected to reach USD 7187.47 million by 2034, growing at a CAGR of 4.65% during the forecast period.
Preclinical Imaging Market size from 2025. The Market is expected to reach USD 7187.47 million by 2034, at a CAGR of 4.65% during the forecast period.
Preclinical Imaging Market CAGR of 4.65% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Preclinical Imaging Market size is USD 7187.47 million from 2025 to 2034.
Preclinical Imaging Market covered By Product, By Application, By End-use
The North America is anticipated to have the highest Market share in the Preclinical Imaging Market.
Agilent Technologies, Bruker Corporation, FUJIFILM SonoSite, General Electric (GE), Mediso Ltd., MILabs B.V., Molecubes, MR Solutions, PerkinElmer, Inc., Siemens A.G., and TriFoil Imaging.
The report includes an in-depth analysis of the Global Preclinical Imaging Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
